Clinical Trial Update: Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial) [Phase 4]

View source ↗

Summary

Phase 4 comparative trial evaluating rosuvastatin/ezetimibe versus atorvastatin/ezetimibe in patients with coronary artery disease and dyslipidemia; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Dyslipidemia

Drugs mentioned

• Atorvastatin/Ezetimibe (atorvastatin; ezetimibe)
• Rosuvastatin/Ezetimibe (rosuvastatin; ezetimibe)

Snippet

Sponsor: Yonsei University | Conditions: Coronary Artery Disease, Dyslipidemias | Phase 4 | Status: ACTIVE_NOT_RECRUITING